rabbit anti pstat1 y701 Search Results


94
R&D Systems rabbit anti pstat1

Rabbit Anti Pstat1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti pstat1/product/R&D Systems
Average 94 stars, based on 1 article reviews
rabbit anti pstat1 - by Bioz Stars, 2026-02
94/100 stars
  Buy from Supplier

96
Cell Signaling Technology Inc primary antibodies against pstat1

Primary Antibodies Against Pstat1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary antibodies against pstat1/product/Cell Signaling Technology Inc
Average 96 stars, based on 1 article reviews
primary antibodies against pstat1 - by Bioz Stars, 2026-02
96/100 stars
  Buy from Supplier

98
Cell Signaling Technology Inc rabbit anti pstat1 y701

Rabbit Anti Pstat1 Y701, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti pstat1 y701/product/Cell Signaling Technology Inc
Average 98 stars, based on 1 article reviews
rabbit anti pstat1 y701 - by Bioz Stars, 2026-02
98/100 stars
  Buy from Supplier

96
Cell Signaling Technology Inc pstat1 y701

Pstat1 Y701, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pstat1 y701/product/Cell Signaling Technology Inc
Average 96 stars, based on 1 article reviews
pstat1 y701 - by Bioz Stars, 2026-02
96/100 stars
  Buy from Supplier

86
New England Biolabs rabbit anti pstat1 y701
Fluticasone propionate suppresses TLR3 and RIG-I-induced interferon responses but does not block type I IFN signalling. a – d BEAS-2B cells were treated with fluticasone propionate at 1 and 10 nM concentrations and stimulated with rhinovirus-A1 or receptor-specific agonists. Cell lysates were collected at 24 h post stimulation. a IFNβ and IFNλ2/3 mRNA expression following RV-A1 stimulation was measured by quantitative PCR. b IFNβ and IFNλ2/3 mRNA expression following poly(I:C) stimulation was measured by quantitative PCR. c IFNβ and IFNλ2/3 mRNA expression following RIG-I agonist (transfected 5′ppp-dsRNA) stimulation was measured by quantitative PCR. Transfected dsRNA lacking the 5′ triphosphate was used as a ‘RIG-I control’. d IFNβ and IFNλ2/3 mRNA expression following MDA-5 agonist (transfected HMW Poly(I:C) directly pre-coupled to the transfection reagent LyoVec) stimulation was measured by quantitative PCR. LyoVec without Poly(I:C) (LyoVec control) was used as a control for transfection. e , f BEAS-2B cells were transfected with interferon-β promoter–reporter constructs together with ΔTRIF, ΔMAVS or vector control (pUNO1) and then treated with fluticasone propionate (FP) 1 or 10 nM or medium control 3 h later. Cells were collected 24 h later and relative light units (RLU) were determined. e IFNβ promoter activity following transfection with ΔTRIF. f IFNβ promoter activity following transfection with ΔMAVS. g , h BEAS-2B cells were treated with fluticasone propionate at 1 and 10 nM concentrations and stimulated with recombinant IFN-β. g 2 ′– 5 ′ OAS, viperin and MX1 mRNA expression at 24 h post stimulation was measured by quantitative PCR. h Cell extracts were collected at 1 h post stimulation and analysed by western blotting with antibodies to <t>pSTAT1</t> <t>Y701,</t> STAT1, pSTAT2 Y690 and STAT2. In a – g , data represent mean (±SEM) comprising three independent experiments, analysed by one-way ANOVA with Bonferroni post test. ns non-significant. * p < 0.05, ** p < 0.01, *** p < 0.001. In h , data shown are representative of results from three independent experiments. i C57BL/6 mice were treated intranasally with fluticasone propionate (20 μg) or vehicle DMSO control and additionally with recombinant 10 4 units IFN-β. Interferon-stimulated genes 2 ′- 5 ′ OAS , and Viperin mRNAs in lung tissue at 8 h post infection were measured by quantitative PCR. Data represents mean (±SEM) of five mice per treatment group, representative of at least two independent experiments. Data were analysed by one-way ANOVA with Bonferroni post test. ns non-significant. * p < 0.05, ** p < 0.01, *** p < 0.001
Rabbit Anti Pstat1 Y701, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti pstat1 y701/product/New England Biolabs
Average 86 stars, based on 1 article reviews
rabbit anti pstat1 y701 - by Bioz Stars, 2026-02
86/100 stars
  Buy from Supplier

98
Cell Signaling Technology Inc pstat1
Fluticasone propionate suppresses TLR3 and RIG-I-induced interferon responses but does not block type I IFN signalling. a – d BEAS-2B cells were treated with fluticasone propionate at 1 and 10 nM concentrations and stimulated with rhinovirus-A1 or receptor-specific agonists. Cell lysates were collected at 24 h post stimulation. a IFNβ and IFNλ2/3 mRNA expression following RV-A1 stimulation was measured by quantitative PCR. b IFNβ and IFNλ2/3 mRNA expression following poly(I:C) stimulation was measured by quantitative PCR. c IFNβ and IFNλ2/3 mRNA expression following RIG-I agonist (transfected 5′ppp-dsRNA) stimulation was measured by quantitative PCR. Transfected dsRNA lacking the 5′ triphosphate was used as a ‘RIG-I control’. d IFNβ and IFNλ2/3 mRNA expression following MDA-5 agonist (transfected HMW Poly(I:C) directly pre-coupled to the transfection reagent LyoVec) stimulation was measured by quantitative PCR. LyoVec without Poly(I:C) (LyoVec control) was used as a control for transfection. e , f BEAS-2B cells were transfected with interferon-β promoter–reporter constructs together with ΔTRIF, ΔMAVS or vector control (pUNO1) and then treated with fluticasone propionate (FP) 1 or 10 nM or medium control 3 h later. Cells were collected 24 h later and relative light units (RLU) were determined. e IFNβ promoter activity following transfection with ΔTRIF. f IFNβ promoter activity following transfection with ΔMAVS. g , h BEAS-2B cells were treated with fluticasone propionate at 1 and 10 nM concentrations and stimulated with recombinant IFN-β. g 2 ′– 5 ′ OAS, viperin and MX1 mRNA expression at 24 h post stimulation was measured by quantitative PCR. h Cell extracts were collected at 1 h post stimulation and analysed by western blotting with antibodies to <t>pSTAT1</t> <t>Y701,</t> STAT1, pSTAT2 Y690 and STAT2. In a – g , data represent mean (±SEM) comprising three independent experiments, analysed by one-way ANOVA with Bonferroni post test. ns non-significant. * p < 0.05, ** p < 0.01, *** p < 0.001. In h , data shown are representative of results from three independent experiments. i C57BL/6 mice were treated intranasally with fluticasone propionate (20 μg) or vehicle DMSO control and additionally with recombinant 10 4 units IFN-β. Interferon-stimulated genes 2 ′- 5 ′ OAS , and Viperin mRNAs in lung tissue at 8 h post infection were measured by quantitative PCR. Data represents mean (±SEM) of five mice per treatment group, representative of at least two independent experiments. Data were analysed by one-way ANOVA with Bonferroni post test. ns non-significant. * p < 0.05, ** p < 0.01, *** p < 0.001
Pstat1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pstat1/product/Cell Signaling Technology Inc
Average 98 stars, based on 1 article reviews
pstat1 - by Bioz Stars, 2026-02
98/100 stars
  Buy from Supplier

94
fluidigm anti pstat1 y701 58d6
KEY RESOURCES TABLE
Anti Pstat1 Y701 58d6, supplied by fluidigm, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti pstat1 y701 58d6/product/fluidigm
Average 94 stars, based on 1 article reviews
anti pstat1 y701 58d6 - by Bioz Stars, 2026-02
94/100 stars
  Buy from Supplier

94
Cell Signaling Technology Inc anti y701 pstat1 monoclonal antibody
A <t>pSTAT1</t> signaling of IFNω1 (orange), IFNλ3 (blue), and IFNλ4 (red) in Hap1 cells. Curves are fit to a first-order logistic model. Data are presented with mean values and error bars representing ±SEM ( n = 3 biologically independent experiments). B Relative quantification (RQ) of select genes induced by IFNω1, IFNλ3, and IFNλ4 in Hap1 cells treated with saturating concentrations (100 nM) interferon for 6 h as measured by qPCR. Data are presented with mean values. Error bars represent 95% confidence intervals ( n = 3 biologically independent experiments). C Changes in induction of ISG15 or MX1 over time for IFNλ3 and IFNλ4 in Huh7.5.1 cells at a range of concentrations (~0.5, 1.5, 5, and 15 nM). Statistical significance determined by a two-tailed student t -test. Data are presented as mean values ± SD ( n = 3 biologically independent experiments; * = p ≤ 0.05, ** = p ≤ 0.01, *** = p ≤ 0.001). D Intracellular HCV genomic RNA level over time following treatment with IFNω1, IFNλ3, or IFNλ4 in Huh7.5.1 cells. Statistical significance was determined by a two-tailed student t -test. Data are presented as mean values ± SD ( n = 3 biologically independent experiments; * = p ≤ 0.05, ** = p ≤ 0.01).
Anti Y701 Pstat1 Monoclonal Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti y701 pstat1 monoclonal antibody/product/Cell Signaling Technology Inc
Average 94 stars, based on 1 article reviews
anti y701 pstat1 monoclonal antibody - by Bioz Stars, 2026-02
94/100 stars
  Buy from Supplier

94
fluidigm 153 eu pstat1
A <t>pSTAT1</t> signaling of IFNω1 (orange), IFNλ3 (blue), and IFNλ4 (red) in Hap1 cells. Curves are fit to a first-order logistic model. Data are presented with mean values and error bars representing ±SEM ( n = 3 biologically independent experiments). B Relative quantification (RQ) of select genes induced by IFNω1, IFNλ3, and IFNλ4 in Hap1 cells treated with saturating concentrations (100 nM) interferon for 6 h as measured by qPCR. Data are presented with mean values. Error bars represent 95% confidence intervals ( n = 3 biologically independent experiments). C Changes in induction of ISG15 or MX1 over time for IFNλ3 and IFNλ4 in Huh7.5.1 cells at a range of concentrations (~0.5, 1.5, 5, and 15 nM). Statistical significance determined by a two-tailed student t -test. Data are presented as mean values ± SD ( n = 3 biologically independent experiments; * = p ≤ 0.05, ** = p ≤ 0.01, *** = p ≤ 0.001). D Intracellular HCV genomic RNA level over time following treatment with IFNω1, IFNλ3, or IFNλ4 in Huh7.5.1 cells. Statistical significance was determined by a two-tailed student t -test. Data are presented as mean values ± SD ( n = 3 biologically independent experiments; * = p ≤ 0.05, ** = p ≤ 0.01).
153 Eu Pstat1, supplied by fluidigm, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/153 eu pstat1/product/fluidigm
Average 94 stars, based on 1 article reviews
153 eu pstat1 - by Bioz Stars, 2026-02
94/100 stars
  Buy from Supplier

Image Search Results


Journal: iScience

Article Title: C9ORF72 suppresses JAK-STAT mediated inflammation

doi: 10.1016/j.isci.2023.106579

Figure Lengend Snippet:

Article Snippet: rabbit anti-pSTAT1 , R and D Systems , Cat# AF2894, RRID: AB_2198137.

Techniques: Recombinant, Enzyme-linked Immunosorbent Assay, Reverse Transcription, Bradford Protein Assay, CRISPR, Plasmid Preparation, Software

Fluticasone propionate suppresses TLR3 and RIG-I-induced interferon responses but does not block type I IFN signalling. a – d BEAS-2B cells were treated with fluticasone propionate at 1 and 10 nM concentrations and stimulated with rhinovirus-A1 or receptor-specific agonists. Cell lysates were collected at 24 h post stimulation. a IFNβ and IFNλ2/3 mRNA expression following RV-A1 stimulation was measured by quantitative PCR. b IFNβ and IFNλ2/3 mRNA expression following poly(I:C) stimulation was measured by quantitative PCR. c IFNβ and IFNλ2/3 mRNA expression following RIG-I agonist (transfected 5′ppp-dsRNA) stimulation was measured by quantitative PCR. Transfected dsRNA lacking the 5′ triphosphate was used as a ‘RIG-I control’. d IFNβ and IFNλ2/3 mRNA expression following MDA-5 agonist (transfected HMW Poly(I:C) directly pre-coupled to the transfection reagent LyoVec) stimulation was measured by quantitative PCR. LyoVec without Poly(I:C) (LyoVec control) was used as a control for transfection. e , f BEAS-2B cells were transfected with interferon-β promoter–reporter constructs together with ΔTRIF, ΔMAVS or vector control (pUNO1) and then treated with fluticasone propionate (FP) 1 or 10 nM or medium control 3 h later. Cells were collected 24 h later and relative light units (RLU) were determined. e IFNβ promoter activity following transfection with ΔTRIF. f IFNβ promoter activity following transfection with ΔMAVS. g , h BEAS-2B cells were treated with fluticasone propionate at 1 and 10 nM concentrations and stimulated with recombinant IFN-β. g 2 ′– 5 ′ OAS, viperin and MX1 mRNA expression at 24 h post stimulation was measured by quantitative PCR. h Cell extracts were collected at 1 h post stimulation and analysed by western blotting with antibodies to pSTAT1 Y701, STAT1, pSTAT2 Y690 and STAT2. In a – g , data represent mean (±SEM) comprising three independent experiments, analysed by one-way ANOVA with Bonferroni post test. ns non-significant. * p < 0.05, ** p < 0.01, *** p < 0.001. In h , data shown are representative of results from three independent experiments. i C57BL/6 mice were treated intranasally with fluticasone propionate (20 μg) or vehicle DMSO control and additionally with recombinant 10 4 units IFN-β. Interferon-stimulated genes 2 ′- 5 ′ OAS , and Viperin mRNAs in lung tissue at 8 h post infection were measured by quantitative PCR. Data represents mean (±SEM) of five mice per treatment group, representative of at least two independent experiments. Data were analysed by one-way ANOVA with Bonferroni post test. ns non-significant. * p < 0.05, ** p < 0.01, *** p < 0.001

Journal: Nature Communications

Article Title: Corticosteroid suppression of antiviral immunity increases bacterial loads and mucus production in COPD exacerbations

doi: 10.1038/s41467-018-04574-1

Figure Lengend Snippet: Fluticasone propionate suppresses TLR3 and RIG-I-induced interferon responses but does not block type I IFN signalling. a – d BEAS-2B cells were treated with fluticasone propionate at 1 and 10 nM concentrations and stimulated with rhinovirus-A1 or receptor-specific agonists. Cell lysates were collected at 24 h post stimulation. a IFNβ and IFNλ2/3 mRNA expression following RV-A1 stimulation was measured by quantitative PCR. b IFNβ and IFNλ2/3 mRNA expression following poly(I:C) stimulation was measured by quantitative PCR. c IFNβ and IFNλ2/3 mRNA expression following RIG-I agonist (transfected 5′ppp-dsRNA) stimulation was measured by quantitative PCR. Transfected dsRNA lacking the 5′ triphosphate was used as a ‘RIG-I control’. d IFNβ and IFNλ2/3 mRNA expression following MDA-5 agonist (transfected HMW Poly(I:C) directly pre-coupled to the transfection reagent LyoVec) stimulation was measured by quantitative PCR. LyoVec without Poly(I:C) (LyoVec control) was used as a control for transfection. e , f BEAS-2B cells were transfected with interferon-β promoter–reporter constructs together with ΔTRIF, ΔMAVS or vector control (pUNO1) and then treated with fluticasone propionate (FP) 1 or 10 nM or medium control 3 h later. Cells were collected 24 h later and relative light units (RLU) were determined. e IFNβ promoter activity following transfection with ΔTRIF. f IFNβ promoter activity following transfection with ΔMAVS. g , h BEAS-2B cells were treated with fluticasone propionate at 1 and 10 nM concentrations and stimulated with recombinant IFN-β. g 2 ′– 5 ′ OAS, viperin and MX1 mRNA expression at 24 h post stimulation was measured by quantitative PCR. h Cell extracts were collected at 1 h post stimulation and analysed by western blotting with antibodies to pSTAT1 Y701, STAT1, pSTAT2 Y690 and STAT2. In a – g , data represent mean (±SEM) comprising three independent experiments, analysed by one-way ANOVA with Bonferroni post test. ns non-significant. * p < 0.05, ** p < 0.01, *** p < 0.001. In h , data shown are representative of results from three independent experiments. i C57BL/6 mice were treated intranasally with fluticasone propionate (20 μg) or vehicle DMSO control and additionally with recombinant 10 4 units IFN-β. Interferon-stimulated genes 2 ′- 5 ′ OAS , and Viperin mRNAs in lung tissue at 8 h post infection were measured by quantitative PCR. Data represents mean (±SEM) of five mice per treatment group, representative of at least two independent experiments. Data were analysed by one-way ANOVA with Bonferroni post test. ns non-significant. * p < 0.05, ** p < 0.01, *** p < 0.001

Article Snippet: The following primary antibodies were used: rabbit anti-pSTAT1 Y701 (1:1000 diluted; New England BioLabs), anti-pSTAT2 Y690 (1:1000, New England BioLabs), anti-STAT1 (1:1000 diluted; New England BioLabs) and anti-STAT2 (1:1000 diluted; New England BioLabs).

Techniques: Blocking Assay, Expressing, Real-time Polymerase Chain Reaction, Transfection, Construct, Plasmid Preparation, Activity Assay, Recombinant, Western Blot, Infection

KEY RESOURCES TABLE

Journal: Cell reports

Article Title: A FLCN-TFE3 Feedback Loop Prevents Excessive Glycogenesis and Phagocyte Activation by Regulating Lysosome Activity

doi: 10.1016/j.celrep.2020.01.042

Figure Lengend Snippet: KEY RESOURCES TABLE

Article Snippet: Anti-pStat1 [Y701] (58D6)-153Eu , Fluidigm , Cat#3153003A; RRID: AB_2811248.

Techniques: Purification, Blocking Assay, Recombinant, Transfection, Flow Cytometry, Magnetic Beads, Lysis, Extraction, SYBR Green Assay, Staining, shRNA, Sequencing, Plasmid Preparation, Software

A pSTAT1 signaling of IFNω1 (orange), IFNλ3 (blue), and IFNλ4 (red) in Hap1 cells. Curves are fit to a first-order logistic model. Data are presented with mean values and error bars representing ±SEM ( n = 3 biologically independent experiments). B Relative quantification (RQ) of select genes induced by IFNω1, IFNλ3, and IFNλ4 in Hap1 cells treated with saturating concentrations (100 nM) interferon for 6 h as measured by qPCR. Data are presented with mean values. Error bars represent 95% confidence intervals ( n = 3 biologically independent experiments). C Changes in induction of ISG15 or MX1 over time for IFNλ3 and IFNλ4 in Huh7.5.1 cells at a range of concentrations (~0.5, 1.5, 5, and 15 nM). Statistical significance determined by a two-tailed student t -test. Data are presented as mean values ± SD ( n = 3 biologically independent experiments; * = p ≤ 0.05, ** = p ≤ 0.01, *** = p ≤ 0.001). D Intracellular HCV genomic RNA level over time following treatment with IFNω1, IFNλ3, or IFNλ4 in Huh7.5.1 cells. Statistical significance was determined by a two-tailed student t -test. Data are presented as mean values ± SD ( n = 3 biologically independent experiments; * = p ≤ 0.05, ** = p ≤ 0.01).

Journal: Nature Communications

Article Title: Structural studies of the IFNλ4 receptor complex using cryoEM enabled by protein engineering

doi: 10.1038/s41467-025-56119-y

Figure Lengend Snippet: A pSTAT1 signaling of IFNω1 (orange), IFNλ3 (blue), and IFNλ4 (red) in Hap1 cells. Curves are fit to a first-order logistic model. Data are presented with mean values and error bars representing ±SEM ( n = 3 biologically independent experiments). B Relative quantification (RQ) of select genes induced by IFNω1, IFNλ3, and IFNλ4 in Hap1 cells treated with saturating concentrations (100 nM) interferon for 6 h as measured by qPCR. Data are presented with mean values. Error bars represent 95% confidence intervals ( n = 3 biologically independent experiments). C Changes in induction of ISG15 or MX1 over time for IFNλ3 and IFNλ4 in Huh7.5.1 cells at a range of concentrations (~0.5, 1.5, 5, and 15 nM). Statistical significance determined by a two-tailed student t -test. Data are presented as mean values ± SD ( n = 3 biologically independent experiments; * = p ≤ 0.05, ** = p ≤ 0.01, *** = p ≤ 0.001). D Intracellular HCV genomic RNA level over time following treatment with IFNω1, IFNλ3, or IFNλ4 in Huh7.5.1 cells. Statistical significance was determined by a two-tailed student t -test. Data are presented as mean values ± SD ( n = 3 biologically independent experiments; * = p ≤ 0.05, ** = p ≤ 0.01).

Article Snippet: To quantify activation of pSTAT1, cells were washed thrice with 0.5% PBSA and then stained with an anti-Y701 pSTAT1 monoclonal antibody (Cell Signaling, product #9174S) according to manufacturer instructions.

Techniques: Quantitative Proteomics, Two Tailed Test